Skip to main content

Monolith 02

Advanced Medical AI Research

AI diagnostic tools for diseases that kill disproportionately in South Asia. The diseases that Western AI labs do not build for.

Current focus areas

  • AI-assisted dengue severity prediction from clinical data — platelet trajectories, NS1 antigen levels, and fever curves.
  • Thalassemia genetic-marker identification for Sri Lankan populations.
  • Malaria rapid diagnostic support for rural Sri Lankan clinics.
  • Drug–protein interaction modeling for endemic disease targets using AlphaFold structural predictions.

Phase 01 active. First published research output: December 2026.

Partnership & ethics

Data-partnership discussions active with three Sri Lankan hospital networks.

First published research output: December 2026.

Ethics & data integrity

All medical research is conducted under international ethical standards (COPE, ICMJE, the Helsinki Declaration). Research involving patient data requires IRB/ethics-board approval before access. IRB application status: submitted, pending. Current stage: publicly available datasets only (PubMed, ClinicalTrials.gov). No patient data is processed until approval is received and documented.

Live from the frontier

Recent research

Further reading

Questions

Advanced Medical AI Research — questions

Which diseases does the medical lab research?

The Advanced Medicine laboratory researches AI diagnostic tools for diseases disproportionately affecting South Asia: dengue, malaria, typhoid, and thalassemia. Dengue alone causes an estimated 390 million infections annually (WHO), 96% of them in tropical and subtropical regions including Sri Lanka.

When is the first medical research output?

The first published research output is targeted for December 2026: a computational analysis of binding-site predictions for dengue NS5 polymerase, using AlphaFold-generated structures cross-referenced with existing approved-compound databases for repurposing candidates.

Does ASI Research Lab use patient data?

No patient data is processed until IRB/ethics-board approval is received and documented. All current medical research uses publicly available datasets only — PubMed and ClinicalTrials.gov. Data-partnership discussions are active with Sri Lankan hospital networks.

What ethical standards apply to this research?

Medical research follows COPE guidelines, ICMJE recommendations, and the Helsinki Declaration. Research involving patient data requires IRB approval before access, de-identification before any data enters ASI systems, and a published ethics statement with every output.